KLK3 and prostate carcinoma: However, as it is still difficult to establish an accurate diagnosis simply based on the overexpression of PSA, Karami et al. designed a gold screen-printed electrode to simultaneously detect PSA and myoglobin, a biomarker often co-expressed with PSA, in human serum and urine samples of prostate cancer patients [108].